Millennium Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.5M Sell
202,452
-249,521
-55% -$4.32M ﹤0.01% 2310
2025
Q1
$9.88M Sell
451,973
-123,517
-21% -$2.7M 0.01% 1531
2024
Q4
$18.4M Buy
575,490
+498,104
+644% +$15.9M 0.01% 1146
2024
Q3
$2.23M Sell
77,386
-128,525
-62% -$3.71M ﹤0.01% 2487
2024
Q2
$7.9M Sell
205,911
-579,485
-74% -$22.2M ﹤0.01% 1627
2024
Q1
$46.2M Buy
785,396
+772,869
+6,170% +$45.4M 0.02% 578
2023
Q4
$750K Sell
12,527
-32,602
-72% -$1.95M ﹤0.01% 2988
2023
Q3
$1.72M Sell
45,129
-873,682
-95% -$33.2M ﹤0.01% 2584
2023
Q2
$83.7M Buy
918,811
+370,610
+68% +$33.8M 0.04% 286
2023
Q1
$36.2M Buy
548,201
+528,565
+2,692% +$34.9M 0.02% 630
2022
Q4
$1.02M Sell
19,636
-238,233
-92% -$12.3M ﹤0.01% 3159
2022
Q3
$17.6M Buy
+257,869
New +$17.6M 0.01% 1021
2022
Q2
Sell
-60,505
Closed -$3.07M 5064
2022
Q1
$3.07M Sell
60,505
-251,497
-81% -$12.8M ﹤0.01% 2733
2021
Q4
$14.8M Sell
312,002
-93,380
-23% -$4.41M 0.01% 1240
2021
Q3
$13.4M Buy
+405,382
New +$13.4M 0.01% 1213
2021
Q2
Sell
-158,571
Closed -$6.8M 4961
2021
Q1
$6.8M Sell
158,571
-83,143
-34% -$3.57M ﹤0.01% 1772
2020
Q4
$13.8M Sell
241,714
-674,989
-74% -$38.6M 0.01% 1043
2020
Q3
$27.7K Sell
916,703
-158,547
-15% -$4.78K 0.03% 417
2020
Q2
$35.1M Sell
1,075,250
-282,336
-21% -$9.22M 0.05% 325
2020
Q1
$36.4M Buy
1,357,586
+774,980
+133% +$20.8M 0.08% 137
2019
Q4
$17.8M Sell
582,606
-2,128,655
-79% -$65.2M 0.02% 715
2019
Q3
$65.3M Buy
2,711,261
+667,337
+33% +$16.1M 0.1% 163
2019
Q2
$51.8M Buy
2,043,924
+117,358
+6% +$2.97M 0.08% 274
2019
Q1
$37.6M Buy
1,926,566
+744,181
+63% +$14.5M 0.06% 404
2018
Q4
$15.6M Buy
1,182,385
+75,276
+7% +$993K 0.02% 755
2018
Q3
$19.7M Buy
1,107,109
+213,649
+24% +$3.8M 0.02% 778
2018
Q2
$19.7M Buy
+893,460
New +$19.7M 0.03% 801